Siegfried Hekimi
Corporate Officer/Principal bij McGill University
Profiel
Siegfried Hekimi is the founder of Chronogen, Inc. which was founded in 1998.
He held the title of Chief Scientific Officer from 2009 to 2010.
Currently, he is a Professor at McGill University.
Dr. Hekimi obtained a doctorate degree from the University of Geneva.
Actieve functies van Siegfried Hekimi
| Bedrijven | Functie | Begin |
|---|---|---|
| McGill University | Corporate Officer/Principal | - |
Eerdere bekende functies van Siegfried Hekimi
| Bedrijven | Functie | Einde |
|---|---|---|
Chronogen, Inc.
 Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | Founder | 23-04-2010 |
Opleiding van Siegfried Hekimi
| University of Geneva | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | Health Technology |
